EVI to support GAVI's malaria learning agenda
- EVI
- 2 days ago
- 1 min read
Updated: 1 day ago
New EVI-led project will assess the impact of enhancing seasonal malaria vaccination in Guinea and Benin. The findings could shape future malaria vaccination policies and support national malaria vaccine programmes in Africa.
11 April 2025
The European Vaccine Initiative (EVI) is leading efforts to evaluate the feasibility and impact of a seasonal intensification strategy for malaria vaccination in regions with highly seasonal malaria transmission. The study, conducted in Guinea and Benin, will compare this approach to the standard age-based vaccination schedule to determine its feasibility, implementation challenges, cost-effectiveness, and impact on vaccine uptake and malaria burden.
EVI is partnering with the National Malaria Programmes of Guinea and Benin, Université de Thiès in Senegal, the Special Programme for Research and Training in Tropical Diseases (TDR), the London School of Hygiene & Tropical Medicine, the University of Conakry, and the CREC/LSHTM Collaborative Research Programme in Cotonou, Benin, to assess the impact on uptake, coverage, costs and malaria burden of seasonal intensification of malaria vaccination.
To kick start project activities, partners met in Guinea on 2-3 April and in Benin on April 10-11, where next steps and implementation plans were discussed.
This initiative marks EVI’s first collaboration with Gavi, the Vaccine Alliance, supporting global efforts to establish the Malaria Vaccine Programme (MVP) and helping countries integrate malaria vaccination into broader malaria prevention and control strategies.
If successful, the findings could shape national malaria vaccination policies, optimising protection for children in malaria-endemic regions and support the long-term goal of eradicating malaria.
Project to enhance seasonal malaria vaccination from European Vaccine Initiative to Guinea and Benin, through Gavi's Malaria Learning Agenda funding.